SNDL (NASDAQ:SNDL) Posts Earnings Results

SNDL (NASDAQ:SNDL) announced its earnings results on Tuesday. The company reported ($0.02) earnings per share for the quarter, FiscalAI reports. SNDL had a negative net margin of 1.19% and a negative return on equity of 1.02%. The business had revenue of $165.94 million during the quarter, compared to analyst estimates of $166.26 million.

Here are the key takeaways from SNDL’s conference call:

• Second-quarter results weakened: Net revenue fell 3.7% year over year to CAD 235.8 million, gross profit declined 16.6% to CAD 56.3 million, and adjusted operating loss was CAD 7 million. Liquor Retail and Cannabis Operations were the largest contributors to the decline.
• Cannabis Operations faced significant production inefficiencies: Revenue declined 10.1%, gross margin fell to 1.8%, and adjusted operating loss widened to CAD 9 million, with management attributing roughly 80%–90% of the gross-margin shortfall to the Jeeter production ramp-up. Some cost pressure is expected to persist over the coming months.
• Balance-sheet strength supported shareholder returns and strategic flexibility: SNDL held CAD 183.2 million of unrestricted cash and no debt at quarter-end, repurchased CAD 23.3 million of shares in Q2, and has reduced its share count by approximately 7% since Q4 2024. Management also expects more than CAD 20 million of incremental operating income from profit-enhancement initiatives, mostly later this year.
• Parallel restructuring created a potential U.S. cannabis growth platform: Subject to legal, regulatory, accounting, and Nasdaq requirements, SNDL expects to gain direct control of Parallel’s medical cannabis operations in Florida, Texas, and Massachusetts. The platform includes 56 retail locations, approximately 800 employees, and near-term annualized revenue of about CAD 150 million.
• Management expects mixed but improving conditions in the second half: Cannabis retail margins improved despite negative same-store sales, and SNDL anticipates low-single-digit market growth in Alberta and Ontario during the second half. Liquor demand remains uncertain, although management expects reduced promotional intensity to support flat-to-improving margins.

SNDL Trading Down 9.6%

Shares of NASDAQ SNDL opened at $1.22 on Wednesday. SNDL has a fifty-two week low of $1.21 and a fifty-two week high of $2.89. The firm has a market capitalization of $314.03 million, a P/E ratio of -40.67 and a beta of 0.92. The company has a debt-to-equity ratio of 0.12, a current ratio of 4.84 and a quick ratio of 3.25. The company’s 50 day simple moving average is $1.38 and its 200 day simple moving average is $1.45.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on SNDL shares. Zacks Research raised shares of SNDL from a “strong sell” rating to a “hold” rating in a report on Thursday, May 28th. Weiss Ratings reiterated a “sell (e+)” rating on shares of SNDL in a research report on Thursday, June 11th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $5.00.

More SNDL News

Here are the key news stories impacting SNDL this week:

• Positive Sentiment: SNDL completed its acquisition of selected Parallel assets, expanding into medical cannabis markets in Florida, Texas and Massachusetts. The transaction adds 56 retail locations and three cultivation and manufacturing facilities, with approximately US$150 million in annualized revenue. It also extinguished roughly US$842 million of Parallel’s legacy debt. SNDL Announces Completion of Parallel Asset Acquisition
• Positive Sentiment: Management highlighted strong liquidity, an essentially debt-free balance sheet and accelerated share repurchases, which could support per-share value and provide financial flexibility for further consolidation. SNDL Q2 2026 Earnings Call Highlights
• Neutral Sentiment: SNDL currently has indirect majority economic exposure to the Parallel assets and expects a possible transition to direct consolidation in the coming months. That outcome remains subject to legal, regulatory, Nasdaq and accounting requirements, creating uncertainty over when the acquisition will affect reported financial results. SNDL Completes Parallel Asset Acquisition
• Negative Sentiment: Second-quarter revenue was C$165.94 million, slightly below the C$166.26 million analyst consensus, while revenue contracted for a second consecutive quarter. Weakness in the liquor and cannabis segments weighed on the topline and raised concerns about near-term demand and operating momentum. SNDL Shares Slide as Liquor and Cannabis Segments Drag Revenue
• Negative Sentiment: SNDL reported a C$0.02 quarterly loss per share, worse than the expected C$0.01 loss and below the C$0.01 profit recorded a year earlier. The miss, negative net margin and ongoing profitability challenges appear to be the main reasons investors have reacted negatively to the results. SNDL Reports Q2 Loss and Lags Revenue Estimates

Institutional Trading of SNDL

Institutional investors and hedge funds have recently made changes to their positions in the business. Arrowstreet Capital Limited Partnership lifted its stake in shares of SNDL by 718.2% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 4,622,786 shares of the company’s stock valued at $12,325,000 after purchasing an additional 4,057,790 shares during the period. JPMorgan Chase & Co. bought a new stake in SNDL in the third quarter valued at about $5,039,000. HRT Financial LP bought a new stake in SNDL in the fourth quarter valued at about $1,346,000. Lazard Asset Management LLC acquired a new position in SNDL in the third quarter valued at about $2,130,000. Finally, Millennium Management LLC lifted its stake in SNDL by 120.1% in the fourth quarter. Millennium Management LLC now owns 1,156,161 shares of the company’s stock valued at $1,919,000 after buying an additional 630,870 shares during the period.

About SNDL

SNDL Inc, formerly known as Sundial Growers Inc, is a Canada-based consumer packaged goods company focused on the production, manufacturing and distribution of cannabis products. Headquartered in Calgary, Alberta, SNDL operates multiple cultivation and processing facilities across Canada, including indoor and hybrid greenhouses in British Columbia and Ontario. The company serves both adult-use and medical cannabis markets, supplying provincial distributors as well as operating through its own wholesale and retail networks.

The company’s product portfolio spans dried flower, pre-rolls, vape cartridges, cannabis oils, edibles and infused beverages under a variety of in-house brands.